Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance.
about
3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation.Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.Drug therapies for HIV-related metabolic disorders.Contending with the chronicity of HIV and associated comorbidities.
P2860
Sitagliptin Reduces Inflammation and Chronic Immune Cell Activation in HIV+ Adults With Impaired Glucose Tolerance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@ast
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@en
type
label
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@ast
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@en
prefLabel
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@ast
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@en
P2093
P2860
P356
P1476
Sitagliptin Reduces Inflammati ...... th Impaired Glucose Tolerance.
@en
P2093
Conor Best
Dominic N Reeds
Erin Laciny
Heidi Struthers
Kevin E Yarasheski
Michael Royal
P2860
P304
P356
10.1210/JC.2015-1531
P407
P577
2015-05-04T00:00:00Z